UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 731

Sortiert nach

Randomized Trial of an Allogeneic Melanoma Lysate Vaccine With Low-Dose Interferon Alfa-2b Compared With High-Dose Interferon Alfa-2b for Resected Stage III Cutaneous Melanoma

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2078-2085

2007

Link zum Volltext

Verfügbarkeit prüfen

Active Immunotherapy of Metastatic Melanoma with Allogeneic Melanoma Lysates and Interferon α

Clinical cancer research, 2002-12, Vol.8 (12), p.3696-3701

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Large Multivalent Immunogen Derived from Melanoma Lysates in Patients with Disseminated Melanoma

Clinical cancer research, 2004-01, Vol.10 (1), p.76-83

2004

Link zum Volltext

Verfügbarkeit prüfen

Combinations of anticancer drugs and immunotherapy

Cancer Immunology, Immunotherapy, 2003-11, Vol.52 (11), p.686-692

Mitchell, Malcolm S

2003

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy as part of combinations for the treatment of cancer

International immunopharmacology, 2003-08, Vol.3 (8), p.1051-1059

Mitchell, Malcolm S

2003

Link zum Volltext

Verfügbarkeit prüfen

Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART‐1

European journal of immunology, 2000, Vol.30 (8), p.2115-2124

2000

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of Adoptive Immunotherapy With Cytolytic T Lymphocytes Immunized Against a Tyrosinase Epitope

Journal of clinical oncology, 2002-02, Vol.20 (4), p.1075-1086

Mitchell, M. S.

2002

Link zum Volltext

Verfügbarkeit prüfen

tyranny of statistics in medicine: a critique of unthinking adherence to an arbitrary p value

Cancer Immunology, Immunotherapy, 2010-08, Vol.59 (8), p.1137-1140

2010

Link zum Volltext

Verfügbarkeit prüfen

Analysis of in vitro immunization: generation of cytotoxic t-lymphocytes against allogeneic melanoma cells with tumor lysate-loaded or tumor RNA-transfected antigen-presenting cells

Cancer Immunology, Immunotherapy, 2003-03, Vol.52 (3), p.171-178

2003

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy for melanoma: the resultant of conflicting vectors

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2043-2045

Mitchell, Malcolm S

2004

Link zum Volltext

Verfügbarkeit prüfen

The cytotoxic T cell response to peptide analogs of the HLA-A0201-restricted MUC1 signal sequence epitope, M1.2

Cancer Immunology, Immunotherapy, 2007-03, Vol.56 (3), p.287-301

2007

Link zum Volltext

Verfügbarkeit prüfen

A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes

Cancer research (Chicago, Ill.), 2000-11, Vol.60 (22), p.6448-6456

2000

Link zum Volltext

Verfügbarkeit prüfen

Cancer vaccines, a critical review--Part I

Current opinion in investigational drugs (London, England : 2000), 2002-01, Vol.3 (1), p.140

Mitchell, Malcolm S

2002

Link zum Volltext

Verfügbarkeit prüfen

Cancer vaccines, a critical review--Part II

Current opinion in investigational drugs (London, England : 2000), 2002-01, Vol.3 (1), p.150

Mitchell, Malcolm S

2002

Link zum Volltext

Verfügbarkeit prüfen

Synopsis of the 5th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay

Cancer Immunology, Immunotherapy, 2003-10, Vol.52 (10), p.655-660

2003

Link zum Volltext

Verfügbarkeit prüfen

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant

Cancer research (Chicago, Ill.), 1988-10, Vol.48 (20), p.5883-5893

1988

Link zum Volltext

Verfügbarkeit prüfen

Immunity to Cancer

Reif, Arnold

1, 1985

Link zum Volltext

Verfügbarkeit prüfen

Therapy of Melanoma with Allogeneic Melanoma Lysates Alone or with Interferon-Alfa

Cancer investigation, 2002-01, Vol.20 (5-6), p.759-768

2002

Link zum Volltext

Verfügbarkeit prüfen

Radiation improves intratumoral gene therapy for induction of cancer vaccine in murine prostate carcinoma

Human gene therapy, 2003-05, Vol.14 (8), p.763-775

2003

Link zum Volltext

Verfügbarkeit prüfen

Synopsis of the 4th Walker's Cay Meeting on Cancer Vaccines, 7-10 March 2002

Cancer Immunology, Immunotherapy, 2002-12, Vol.51 (11-12), p.674-676

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope

Journal of clinical oncology, 2002-02, Vol.20 (4), p.1075-1086

2002

Link zum Volltext

Verfügbarkeit prüfen

In Reply

Journal of clinical oncology, 2007-10, Vol.25 (29), p.4693-4695

Mitchell, Malcolm S.

2007

Link zum Volltext

Verfügbarkeit prüfen

T-Cell—Mediated Immunity to Carcinoembryonic Antigen in Humans: an Example of “Swimming Upstream”?

JNCI : Journal of the National Cancer Institute, 1995-07, Vol.87 (13), p.949-951

Mitchell, M S

1995

Link zum Volltext

Verfügbarkeit prüfen

Protection against experimental cerebral metastases of murine melanoma B16 by active immunization

Cancer research (Chicago, Ill.), 1993-03, Vol.53 (5), p.1113-1121

1993

Link zum Volltext

Verfügbarkeit prüfen

Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil

Cancer research (Chicago, Ill.), 1984-09, Vol.44 (9), p.4144-4150

1984

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 731

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(580)
Mit Volltextzugriff
(638)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Randomized Trial of an Allogeneic Melanoma Lysate Vaccine With Low-Dose Interferon Alfa-2b Compared With High-Dose Interferon Alfa-2b for Resected Stage III Cutaneous Melanoma

Active Immunotherapy of Metastatic Melanoma with Allogeneic Melanoma Lysates and Interferon α

Phase I Trial of Large Multivalent Immunogen Derived from Melanoma Lysates in Patients with Disseminated Melanoma

Combinations of anticancer drugs and immunotherapy

Immunotherapy as part of combinations for the treatment of cancer

Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART‐1

Phase I Trial of Adoptive Immunotherapy With Cytolytic T Lymphocytes Immunized Against a Tyrosinase Epitope

tyranny of statistics in medicine: a critique of unthinking adherence to an arbitrary p value

Analysis of in vitro immunization: generation of cytotoxic t-lymphocytes against allogeneic melanoma cells with tumor lysate-loaded or tumor RNA-transfected antigen-presenting cells

Chemotherapy for melanoma: the resultant of conflicting vectors

The cytotoxic T cell response to peptide analogs of the HLA-A0201-restricted MUC1 signal sequence epitope, M1.2

A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes

Cancer vaccines, a critical review--Part I

Cancer vaccines, a critical review--Part II

Synopsis of the 5th annual Cancer Vaccines and Immunotherapy Colloquium at Walker's Cay

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant

Immunity to Cancer

Therapy of Melanoma with Allogeneic Melanoma Lysates Alone or with Interferon-Alfa

Radiation improves intratumoral gene therapy for induction of cancer vaccine in murine prostate carcinoma

Synopsis of the 4th Walker's Cay Meeting on Cancer Vaccines, 7-10 March 2002

Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope

In Reply

T-Cell—Mediated Immunity to Carcinoembryonic Antigen in Humans: an Example of “Swimming Upstream”?

Protection against experimental cerebral metastases of murine melanoma B16 by active immunization

Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil

Suchergebnisse filtern